Current research in the RESC is focused on the application of biophotonics and imaging to cancer screening and diagnosis and also to the monitoring of cancer treatment response. We are interested in developing new technologies for early diagnosis and for effective treatment and monitoring to improve prognosis and overall survival in patients for a broad range of diseases including cancer and autoimmune diseases.

TU Dublin is a partner in the PRTLI funded National Biophotonics and Imaging Platform.